Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized, double-blind, controlled trial of recombinant herpes zoster vaccine (CHO cells) in adults ≥40 years
CTR20254239Phase 2Active
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant herpes zoster vaccine (CHO cells) in herpes zoster (HZ), sponsored by Shanghai Institute of Biological Products. Started Oct 2025; status: active.
02
Drugs
recombinant herpes zoster vaccine (CHO cells)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20254239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254239.